ReviewJournal of clinical hypertension (Greenwich, Conn.)2011

Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers.

Prakash DeedwaniaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.